Valuation: Oscotec Inc.

Market Cap 1,21100Cr 90Cr 82Cr 76Cr 69Cr 129.27Cr 8.36TCr 135.86Cr 921.94Cr 366.42Cr 4.57TCr 338.65Cr 331.51Cr 14TCr P/E 2026 *
37.6x
P/E 2027 * 10.1x
Enterprise Value 102.59Cr 8L 7L 6L 6L 10.95L 7.08Cr 11.51L 78.11L 31.04L 3.87Cr 28.69L 28.09L 12Cr EV / Sales 2026 *
12.2x
EV / Sales 2027 * 4.72x
Free-Float
72.01%
Yield 2026 *
-
Yield 2027 * -
1 day-3.06%
1 week-11.59%
Current month-13.17%
1 month-16.27%
3 months-13.76%
6 months-18.95%
Current year-29.98%
1 week 31,400
Extreme 31400.00000000
36,700
1 month 31,400
Extreme 31400.00000000
39,450
Current year 27,300
Extreme 27300
60,200
1 year 27,300
Extreme 27300
66,000
3 years 18,000
Extreme 18000
66,000
5 years 15,850
Extreme 15850
66,000
10 years 5,630
Extreme 5630
71,500
Manager TitleAgeSince
Chief Executive Officer 64 26/03/2020
Corporate Officer/Principal 54 01/09/1999
Chief Tech/Sci/R&D Officer 63 -
Director TitleAgeSince
Director/Board Member 54 01/09/1999
Director/Board Member 64 26/03/2020
Director/Board Member 66 30/03/2023
Date Insider Type Main position Quantity % Market Cap. Importance
24/07/25 Buy 500 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
-3.06%-11.59%-42.14%+61.56% 90Cr
-0.30%-6.68%+27.12%+127.32% 1,20000Cr
+1.25%-5.35%+32.65%+78.98% 65TCr
+0.94%-2.99%+21.13%+106.30% 51TCr
-0.60%-1.95%+25.73%+67.00% 38TCr
+0.69%-9.50%+36.78%+30.83% 33TCr
+0.41%-4.70%+24.18%+50.18% 29TCr
+0.81%-4.08%-2.95%+31.59% 27TCr
-0.15%-6.45%+29.06%+65.76% 24TCr
-0.06%-0.98%+31.42%+122.83% 21TCr
Average -0.01%-5.04%+18.30%+74.24% 41TCr
Weighted average by Cap. +0.30%-5.19%+26.01%+87.87%

Financials

2026 *2027 *
Net sales 8.4TCr 6.26Cr 5.7Cr 5.25Cr 4.78Cr 8.97Cr 579.81Cr 9.42Cr 64Cr 25Cr 316.69Cr 23Cr 23Cr 993.9Cr 19TCr 14Cr 13Cr 12Cr 11Cr 20Cr 1.33TCr 22Cr 146.19Cr 58Cr 723.86Cr 54Cr 53Cr 2.27TCr
Net income 3.2TCr 2.39Cr 2.17Cr 2Cr 1.82Cr 3.42Cr 220.88Cr 3.59Cr 24Cr 9.68Cr 120.64Cr 8.95Cr 8.76Cr 378.63Cr 12TCr 8.87Cr 8.08Cr 7.44Cr 6.77Cr 13Cr 821.39Cr 13Cr 91Cr 36Cr 448.64Cr 33Cr 33Cr 1.41TCr
Net Debt -18TCr -14Cr -13Cr -12Cr -11Cr -20Cr -1.28TCr -21Cr -140.86Cr -56Cr -697.47Cr -52Cr -51Cr -2.19TCr -30TCr -23Cr -21Cr -19Cr -17Cr -32Cr -2.1TCr -34Cr -231.46Cr -92Cr -1.15TCr -85Cr -83Cr -3.6TCr
Projected Income Statement - Annual - Oscotec Inc.
Logo Oscotec Inc.
Oscotec Inc is a Korea‑based company primarily engaged in new drug development business. The Company operates four main businesses. The new drug development business primarily mainly researches and develops synthetic new drugs, including therapies for autoimmune diseases, acute myeloid leukemia, refractory solid tumors, Alzheimer’s disease and next‑generation solid tumor treatments designed to overcome drug resistance. The dental bone graft business primarily supplies bone graft materials. The dental barrier membrane business provides own developed absorbable collagen barrier membranes. The functional materials and related products business primarily provide functional materials for osteoporosis prevention and bone health, materials and finished products for arthritis prevention and alleviation, and functional materials for periodontal disease prevention and alleviation.
Employees
57
Date Price Change Volume
20/26/20 ₩31,650.00 -3.06% 73,039
19/26/19 ₩32,650.00 +1.08% 83,518
18/26/18 ₩32,300.00 -1.37% 1,21,015
17/26/17 ₩32,750.00 -4.38% 1,40,307
16/26/16 ₩34,250.00 -4.33% 94,979
Trader
Investor
-
Global
-
Quality
ESG MSCI
CCC
MarketScreener Ratings - Oscotec Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
31,650.00KRW
Average target price
75,000.00KRW
Spread / Average Target
+136.97%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Oscotec Inc.
  1. Stock Market
  2. Stocks
  3. A039200 Stock